We found that CSF p-tau217 correlates stronger than p-tau181 with PET measures of tau and amyloid pathologies in AD and more accurately distinguishes AD dementia from non-AD neurodegenerative disorders. The gene discussed is MAPT; the disease is Alzheimer disease.